4-52038232-C-A

Variant summary

Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong

The NM_000232.5(SGCB):​c.28G>T​(p.Glu10*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000264 in 1,135,578 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000026 ( 0 hom. )

Consequence

SGCB
NM_000232.5 stop_gained

Scores

2
3
2

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:3

Conservation

PhyloP100: 0.615

Publications

0 publications found
Variant links:
Genes affected
SGCB (HGNC:10806): (sarcoglycan beta) This gene encodes a member of the sarcoglycan family. Sarcoglycans are transmembrane components in the dystrophin-glycoprotein complex which help stabilize the muscle fiber membranes and link the muscle cytoskeleton to the extracellular matrix. Mutations in this gene have been associated with limb-girdle muscular dystrophy.[provided by RefSeq, Oct 2008]
SGCB Gene-Disease associations (from GenCC):
  • autosomal recessive limb-girdle muscular dystrophy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • autosomal recessive limb-girdle muscular dystrophy type 2E
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Myriad Women’s Health, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 18 ACMG points.

PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant located near the start codon (<100nt), not predicted to undergo nonsense mediated mRNA decay. There are 87 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 4-52038232-C-A is Pathogenic according to our data. Variant chr4-52038232-C-A is described in ClinVar as Pathogenic. ClinVar VariationId is 534947.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SGCBNM_000232.5 linkc.28G>T p.Glu10* stop_gained Exon 1 of 6 ENST00000381431.10 NP_000223.1
SGCBNM_001440519.1 linkc.28G>T p.Glu10* stop_gained Exon 1 of 5 NP_001427448.1
SGCBNM_001440520.1 linkc.-380G>T 5_prime_UTR_variant Exon 1 of 7 NP_001427449.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SGCBENST00000381431.10 linkc.28G>T p.Glu10* stop_gained Exon 1 of 6 1 NM_000232.5 ENSP00000370839.6
SGCBENST00000506357.5 linkn.13G>T non_coding_transcript_exon_variant Exon 1 of 5 5 ENSP00000421235.1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
0.00000264
AC:
3
AN:
1135578
Hom.:
0
Cov.:
31
AF XY:
0.00000182
AC XY:
1
AN XY:
548368
show subpopulations
African (AFR)
AF:
0.0000421
AC:
1
AN:
23754
American (AMR)
AF:
0.00
AC:
0
AN:
17662
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
16950
East Asian (EAS)
AF:
0.00
AC:
0
AN:
24710
South Asian (SAS)
AF:
0.00
AC:
0
AN:
35138
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
23650
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3098
European-Non Finnish (NFE)
AF:
0.00000212
AC:
2
AN:
945512
Other (OTH)
AF:
0.00
AC:
0
AN:
45104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.408
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Autosomal recessive limb-girdle muscular dystrophy type 2E Pathogenic:2
May 15, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change creates a premature translational stop signal (p.Glu10*) in the SGCB gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SGCB are known to be pathogenic (PMID: 15938573, 18285821). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with SGCB-related conditions. ClinVar contains an entry for this variant (Variation ID: 534947). For these reasons, this variant has been classified as Pathogenic. -

Dec 17, 2024
Palindrome, Gene Kavoshgaran Aria
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Pathogenic:1
Jul 12, 2017
Eurofins Ntd Llc (ga)
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.63
D
BayesDel_noAF
Pathogenic
0.32
CADD
Pathogenic
37
DANN
Uncertain
0.99
Eigen
Uncertain
0.54
Eigen_PC
Uncertain
0.23
FATHMM_MKL
Benign
0.27
N
PhyloP100
0.61
Vest4
0.36
GERP RS
2.9
PromoterAI
0.098
Neutral
Mutation Taster
=5/195
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1448040082; hg19: chr4-52904398; API